Endurant Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-47,649	Closed	-$847K	–	49
2023 Q3	$847K	Buy	+47,649	New	+$847K	0.76%	31
2021 Q2	–	Sell	-14,143	Closed	-$456K	–	78
2021 Q1	$456K	Buy	+14,143	New	+$456K	0.12%	59